NPS Going Strong With Gattex - TheStreet

NPS Going Strong With Gattex

Sales of short bowel syndrome drug Gattex have been strong despite worries over price, says Francois Nader CEO of NPS Pharmaceuticals.
Author:
Publish date:

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.